Zurueck zur Suche

Reporte zur Charge UJ919AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

18Reporte angezeigt
1Todesfaelle
4Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 4 OH 4 NH 2 RI 2 NY 2 DE 1 ME 1 MN 1

VAERS 2614582

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

kritisch
Staat
MI
Alter
97,0
Geschlecht
F
Eingang
13.04.2023
Impfdatum
27.09.2022
Beginn
09.04.2023
Tage bis Beginn
194,0
Dosis
N/A
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory failure Angiogram pulmonary abnormal Asthenia Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Escherichia urinary tract infection Hypotension Hypoxia Illness Intensive care Lethargy Lung infiltration Oxygen saturation decreased Pneumonia

Symptomtext

Discharge Provider: Primary Care Physician at Discharge: DO Admission Date: 4/9/2023 PRESENTING PROBLEM: Shortness of breath [R06.02] Hypoxia [R09.02] AKI (acute kidney injury) [N17.9] Elevated brain natriuretic peptide (BNP) level [R79.89] Multifocal pneumonia [J18.9] Sepsis with acute hypoxic respiratory failure and septic shock, due to unspecified organism [A41.9, R65.21, J96.01] COVID-19 [U07.1] Acute respiratory failure [J96.00] Acute respiratory failure with hypoxemia [J96.01] HOSPITAL COURSE: Patient is a 97 year old with extensive past medical history most significant for CAD, CKD, peripheral vascular disease, MR, hypertension with recent admission from 4/4-4/7 for weakness and near-syncope, diagnosed and treated for Ecoli UTI and diagnosed with COVID-19 on 4/4; presented to hospital ED 4/9 afternoon with dyspnea and lethargy. CXR and CTA with marked bilateral infiltrates suspicious for progression of COVID-19 pneumonia with possible bacterial pneumonia. Hypoxemic requiring HFNC 100%/55LPM. AKI on arrival. Discussion with patient's family established DNR/DNI status. Also developed hypotension and started on peripheral Norepi. She was admitted to MICU for ongoing management. Extensive conversations between providers and family detailed the severity of her illness and comorbidities likely to prevent recovery though continuing aggressive care to establish trajectory. By 4/10AM, off Norepi but still requiring HFNC 95%/55LPM with NRBM to maintain SpO2. AKI worsening. Noted worsening of oxygen needs with frequent desaturations 4/11. Family and DPOA at bedside - decision made to transition to comfort measures. Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Essential hypertension Carotid artery disease Osteoporosis Coronary artery disease involving native coronary artery of native heart without angina pectoris Mitral valve mass Hyperparathyroidism Low back pain Seasonal allergies Secondary hyperparathyroidism of renal origin Mitral valve insufficiency, unspecified etiology Stage 3b chronic kidney disease Leg weakness, bilateral Stress incontinence, female Goals of care, counseling/discussion Anemia in stage 3 chronic kidney disease Actinic keratoses Overactive bladder Other fatigue Vitamin D deficiency Other chronic sinusitis Dizziness Chronic nasal congestion Hoarse voice quality Chronic pain of right knee Recurrent UTI Blepharitis of upper and lower eyelids of both eyes Non-allergic rhinitis Ectropion due to laxity of eyelid, right Primary osteoarthritis involving multiple joints Primary insomnia Cerumen debris on tympanic membrane, left Fall Transient alteration of awareness Acute cystitis without hematuria Acute kidney injury Acute respiratory failure with hypoxemia Septic shock COVID-19
Andere Medikamente
acetaminophen (TYLENOL) 325 MG tablet amLODIPine (NORVASC) 5 MG tablet benzonatate (TESSALON) 100 MG capsule cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) tablet guaiFENesin-dextromethorphan (ROBITUSSIN DM) 100-10 MG/5ML syrup metoprolol su
Allergien
CiprofloxacinDizziness, Edema CodeineNausea and Vomiting MorphineNausea and Vomiting NarcoticsNausea and Vomiting PravastatinMyalgia Sulfa DrugsNausea Only Vicodin [Hydrocodone-acetaminophen]Nausea and Vomiting
Vorherige Impfungen
-

VAERS 2591060

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

kritisch
Staat
MI
Alter
89,0
Geschlecht
F
Eingang
03.03.2023
Impfdatum
30.09.2022
Beginn
25.02.2023
Tage bis Beginn
148,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute myocardial infarction Akinesia Angiogram abnormal Anticoagulant therapy COVID-19 pneumonia Cough Dyspnoea Echocardiogram Echocardiogram abnormal Ejection fraction decreased Fatigue Malaise Sepsis Stress cardiomyopathy Troponin increased Wall motion score index abnormal

Symptomtext

Discharge Provider: MD Primary Care Provider: Admission Date: 2/25/2023 Discharge Date: Mar 2, 2023 PRESENTING PROBLEM: NSTEMI (non-ST elevated myocardial infarction) (HCC) [I21.4] HOSPITAL COURSE: 89 y.o. female with h/o COPD on 2L at baseline, OSA, and HFpEF who presented 2/25/2023 to ED for malaise, fatigue, shortness of breath, and cough, no chest pain. Found to have elevated troponin and sepsis likely 2/2 to COVID Pneumonia. Cardiology consulted, TTE obtained with WMA concerning for atypical stress CMP with akinesis of the mid to distal anteroseptal and inferoseptal segments with preserved Apex wall motion. EF 26% previously 60-65%. Patient completed 48hrs of heparin drip. Upon discussion with cardiology she elected for a more conservative approach and was started on GDMT including metoprolol, spironolactone and Entresto. Plan was to proceed with a CMR and initiate dual anti-platelet therapy for year if there was any evidence of subendocardial infarct on the CMR. However repeat echocardiogram on the day of the planned CMR revealed left ventricular ejection fraction preserved at 59% with minor regional variation in the wall motion. Cardiology then deferred CMR as recovery of patient's cardiac function further confirms diagnosis of mid cavity variant stress-induced cardiomyopathy. Recommendations were made discontinue spironolactone and Entresto and continue your patient's beta blocker metoprolol. From a cardiology standpoint patient was safe for discharge and is to follow-up in the outpatient setting with Cardiology. Furthermore the pertains to patient's COVID pneumonia she completed a course of remdesivir, azithromycin, is to finish complete course of Decadron in the outpatient setting for 4 more days. Patient also received IV iron in the setting of iron deficiency anemia and ongoing cardiomyopathy. An incidental finding of thyroid nodule was noted on patient's CTA and she is to follow-up in the outpatient setting with primary care provider. Patient discharged in stable condition

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Community acquired pneumonia Chronic diastolic congestive heart failure (HCC) Chronic obstructive pulmonary disease with acute exacerbation (HCC) Type 2 diabetes mellitus without complication, with long-term current use of insulin (HCC) Essential hypertension, benign OSA (obstructive sleep apnea) Cecum thickening Asthma Thyroid nodule Mixed stress and urge urinary incontinence Malignant neoplasm of cervix (HCC) Incontinence of feces Hyperlipidemia Essential tremor Diastolic dysfunction Cognitive impairment Chronic respiratory failure with hypoxia and hypercapnia (HCC) Chronic pain of both shoulders Chronic pain of both knees Pneumonia due to COVID-19 virus Takotsubo cardiomyopathy
Andere Medikamente
acetaminophen (TYLENOL) albuterol (PROVENTIL) (2.5 MG/3ML) albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 ascorbic Acid (VITAMIN C) aspirin biotin cholecalciferol (VITAMIN D3) Coenzyme Q10 Cranberry cyanocobalamin dexam
Allergien
Zoster Vaccine LiveFatigue, Shortness of Breath LisinoprilCough
Vorherige Impfungen
Zoster Live Vaccine-Had severe reaction to Shingrix including SOB and Fatigue (03/11/2021)

VAERS 2727325

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

schwer
Staat
NH
Alter
6,2
Geschlecht
M
Eingang
26.12.2023
Impfdatum
03.10.2022
Beginn
05.10.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest X-ray normal Computerised tomogram normal Deep vein thrombosis Pain in extremity Peripheral swelling Ultrasound Doppler abnormal

Symptomtext

Swelling + soreness left lower leg 48 hours post injections. Continued until MD visit 6 weeks post, (11/2023) when diagnosis of DVT left leg (ultrasound). All other tests (chest xray 11/2022), cat scan (02/22/2023), and diagnostic endoscope (June 21, 2023) ? all negative. Rx abixaban started (10mg x 2, then 5 mg x 2, currently 2.5 mg x2) and continuing. Possible link of DVT to simultaneous vaccinations of 10/03/2022 suspected upon preprint publication Oct 2023, and ACIP notice of October 2023 on possible link of simultraneous COVID and influenza vaccines among patients over 65-70 and ischemic stroke. Followup with Dr. (see above) 11/29/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
All imaging test negative (see above )
Aktuelle Erkrankungen
none
Vorgeschichte
arthritis ? left knee (disgnosed but not treated)
Andere Medikamente
Timolol (drops) ; tamsulosi (0.4mg); latanoprost (drops)
Allergien
none
Vorherige Impfungen
-

VAERS 2711466

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

moderat
Staat
MI
Alter
71,0
Geschlecht
F
Eingang
08.11.2023
Impfdatum
11.10.2022
Beginn
09.06.2023
Tage bis Beginn
241,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Alanine aminotransferase increased Angiogram pulmonary abnormal Aspartate aminotransferase increased Asthenia Back pain Blood creatinine increased Blood potassium decreased COVID-19 Chronic obstructive pulmonary disease Computerised tomogram spine abnormal Condition aggravated Cough Dyspnoea Fall Hiatus hernia Hypokalaemia Leukocytosis

Symptomtext

BRIEF OVERVIEW: Admission Date: 6/9/2023 Discharge Date: Jun 12, 2023 Discharge Disposition: home health care DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypokalemia [E87.6] Generalized weakness [R53.1] AKI (acute kidney injury) [N17.9] Fall, initial encounter [W19.XXXA] Left upper lobe consolidation [J18.1] COVID [U07.1] Compression fracture of thoracic vertebra, unspecified thoracic vertebral level, initial encounter [S22.000A] COVID-19 [U07.1] HOSPITAL COURSE: 72 y.o. female COPD requiring 2.5 L O2 at baseline presents to emergency department with complaint of cough and shortness of breath x 3 weeks. Seen by PCP prescribed a 9 day taper of prednisone, completed 7 days. Patient's husband had COVID about a month ago, but patient never tested positive. She unfortunately had her sandal caught and she sustained a fall . She presented with SOB and back pain . Patient presents to emergency department tachycardic with heart rate to 110. She was initially placed on 4 L via nasal cannula but was weaned down to baseline 2.5 L. labs remarkable for potassium 2.8, creatinine 1.55, AST 44, ALT 43. Patient has a leukocytosis of 14.7. COVID-19 positive. Procalcitonin was at 12.9. CTA thorax shows left upper lobe consilidation, mod-severe COPD, hiatal hernia and distal esophageal wall thickening, sclerosis and compression of T9. No evidence of PE. Patient was given 40 mEq of potassium and a 1 L normal saline bolus. CT lumbar and thoracic spine showed age-indeterminate moderate burst fracture T9. Seen and examined, husband and wife appreciative explained diagnosis, plans and need for ff up . Discharged hemodynamically stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hx of adenomatous colonic polyps Moderate COPD (chronic obstructive pulmonary disease) HTN (hypertension) Gastroesophageal reflux disease without esophagitis Chronic respiratory failure with hypoxia Left upper lobe consolidation Nodule of upper lobe of right lung
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ALPRAZolam (XANAX) 0.5 MG tablet Biotin 10000 MCG TABS buPROPion (WELLBUTRIN XL) 300 mg 24 hr tablet Coenzyme Q10 (
Allergien
Fosamax (Alendronic Acid)Itching, Asthma/Shortness of Breath Augmentin [Amoxicillin]Diarrhea, Nausea Only LatexRash Oxycodone-ibuprofenItching PenicillinsRash
Vorherige Impfungen
-

VAERS 2590994

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

moderat
Staat
RI
Alter
66,0
Geschlecht
M
Eingang
03.03.2023
Impfdatum
30.09.2022
Beginn
30.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypoaesthesia Mobility decreased Paraesthesia

Symptomtext

Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: numbess and tingling in legs difficult to move, went away in AM

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2589568

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

moderat
Staat
RI
Alter
78,0
Geschlecht
F
Eingang
01.03.2023
Impfdatum
30.09.2022
Beginn
30.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Hypoaesthesia Immunisation reaction Injection site pain Mobility decreased Pain in extremity Paraesthesia

Symptomtext

Site: Pain at Injection Site-Mild, Systemic: numbness/tingling/pain from hips to feet, unable to move-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: numbness/tingling/pain from hips to feet, unable to move. Happened later in day when patient was home, was hospitalized and hospital came to decision that it was flu vaccine and asked to file VAERs report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2467228

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj919aa

moderat
Staat
MI
Alter
67,0
Geschlecht
F
Eingang
03.10.2022
Impfdatum
01.10.2022
Beginn
01.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Bone pain Dizziness Dyspnoea Headache Pyrexia Swelling Swelling face

Symptomtext

Patient stated swelling all over body and face, join and bone pain, headache, dizziness, difficulty breathing, and fever of 103

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
amiodarone eliquis
Allergien
none
Vorherige Impfungen
-

VAERS 2493876

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

mild
Staat
NH
Alter
71,0
Geschlecht
M
Eingang
31.10.2022
Impfdatum
28.10.2022
Beginn
28.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Musculoskeletal stiffness Neuralgia Odynophagia Pain Pain in extremity

Symptomtext

Patient reported having a sore arm later in the day after receiving vaccine. Then was having stiff neck and nerve pain whenever he moved his head and swallowing larger amounts of food. Was advised to take acetaminophen and ice packs to help with symptoms until Monday where his primary care physician could be contacted in order to further treat the symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
None.
Vorgeschichte
Hyperlipidemia, hypertension.
Andere Medikamente
Eliquis 5mg, Lisinopril 40mg, Pravastatin 80mg
Allergien
No allergies mentioned by patient.
Vorherige Impfungen
-

VAERS 2484146

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ919AA

mild
Staat
-
Alter
72,0
Geschlecht
F
Eingang
20.10.2022
Impfdatum
30.09.2022
Beginn
30.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

left arm pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension, DM, R. Iliotibial Band Syndrome
Andere Medikamente
Albuterol inhaler, Lipitor, Betamethasone valerate topical cream, Calcium carbonate-vitamin D3, Lotrisone cream, losartan, metformin, omeprazole, triamcinolone ointment.
Allergien
Codeine, Naproxen Sodium
Vorherige Impfungen
-

VAERS 2473332

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

mild
Staat
DE
Alter
73,0
Geschlecht
F
Eingang
10.10.2022
Impfdatum
05.10.2022
Beginn
05.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Feeling cold Injection site erythema Injection site pain Injection site swelling Injection site warmth Pain Somnolence

Symptomtext

Freezing cold Extreme body ache Slept 36 hours straight Soreness at injection site Large red, hot, swelling around injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Hashimoto thyroid Obesity Fatty liver SVT
Andere Medikamente
Famotidine 20 mg HCTZ 25 mg Levothyroxine 0.075 mg Pravastatin 40 mg Vitamin C 250 mg Fish oil 1200 mg Aspirin 81 mg D3 50 mcg Centrum multivitamin
Allergien
None known
Vorherige Impfungen
Same symptom ps with COVID booster #1

VAERS 2470842

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

mild
Staat
OH
Alter
67,0
Geschlecht
M
Eingang
06.10.2022
Impfdatum
27.09.2022
Beginn
28.09.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Erythema Flushing Injection site erythema Injection site rash Pyrexia

Symptomtext

Pt called health department on 9/29/22 and reported his s/s started 9/28/22 with red rash on left arm near injection site and his face was flushed and appeared red. Pt reports he also felt like he had low grade fever for few days. Pt also reports he had chills. Pt reports he monitored his rash and fever at home. Pt reports he didn't take any OTC medications. Pt advised to call PCP for worsening s/s and states understanding. Pt said he didn't go to ER or to his family doctor since his injection. Pt reports as of 10/06/22 he is feeling better, face appearance normal, and rash is improved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
sarcoidosis, osteoarthritis, hypothyroidism, pacemaker/defibrillator
Andere Medikamente
levothyroxine, sotalol, athrotec
Allergien
-
Vorherige Impfungen
-

VAERS 2557946

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919aa

gering
Staat
ME
Alter
79,0
Geschlecht
F
Eingang
11.01.2023
Impfdatum
05.10.2022
Beginn
05.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

This resident had already received a Pfizer Bivalent on 9/22/2022 but did not remember

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
MDD, HTN, Liver disease, spinal stenosis
Vorgeschichte
-
Andere Medikamente
none reported
Allergien
Morphine, Effexor, excederin, oxycontin, paxil
Vorherige Impfungen
-

VAERS 2542875

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

gering
Staat
NY
Alter
71,0
Geschlecht
M
Eingang
25.12.2022
Impfdatum
17.12.2022
Beginn
01.12.2022
Tage bis Beginn
-
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Eye irritation Oral discomfort

Symptomtext

Burning sensation In both knees, Eyes, Lips

Weitere VAERSDATA-Felder
Praegender Schweregrund
Burning sensation
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
Sleep Apena High Pressure Blood nerve damage in both legs
Andere Medikamente
OXBUTYNIN 10mg 1XD AMLODIPINE 10mg 1XD GABPENTIN 300mg 3XD DULOXETINE 60mg 1XD ALPRAZOLAM 1mg 3XD
Allergien
PENCILLAN SEA FOOD
Vorherige Impfungen
-

VAERS 2517395

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

gering
Staat
OH
Alter
63,0
Geschlecht
F
Eingang
26.11.2022
Impfdatum
03.11.2022
Beginn
03.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was given a High Dose vaccine when they were under 65 years of age. Patient saw no adverse reactions from the vaccine. It was given by the vaccinating pharmacist at the clinic and reported when the pharmacy manager received all the documentation was received at the store.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2506763

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

gering
Staat
OH
Alter
71,0
Geschlecht
F
Eingang
13.11.2022
Impfdatum
29.09.2022
Beginn
30.09.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Skin warm Swelling Tenderness

Symptomtext

developed a red, slightly swollen, slightly warm, slightly tender 5 cm in diameter area on left arm noted the morning after the injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
right leg pain
Vorgeschichte
hypercholesterolemia
Andere Medikamente
simvastatin
Allergien
penicillin, sulfa
Vorherige Impfungen
-

VAERS 2488403

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

gering
Staat
NY
Alter
80,0
Geschlecht
F
Eingang
25.10.2022
Impfdatum
11.10.2022
Beginn
01.10.2022
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered No adverse event

Symptomtext

Patient received a fluzone high dose quadrivalent vaccine on 10/1/2022 and then received another fluzone high dose quadrivalent 10/11/2022. There are no adverse effects being reported at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2468470

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

gering
Staat
MN
Alter
65,0
Geschlecht
M
Eingang
04.10.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient received a second flu shot in the season. Patient did not report receiving a flu shot already nor did he report receiving any vaccines in the past 4 weeks even though he received a High Dose flu vaccine 1 week prior.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2465693

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ919AA

gering
Staat
OH
Alter
63,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
30.09.2022
Beginn
30.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

The incorrect vaccine was administered, patient was to receive FLUCELVAX 2022-23 PFS 0.5 ml

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-